Published in Law and Health Weekly, October 29th, 2005
The approval is based on seven clinical studies involving more than 1600 patients. The studies all demonstrate that Cipralex is an effective and well-tolerated drug for the treatment of GAD.
It is estimated more than half of the patients suffering from GAD also suffer from another psychiatric disorder, primarily depression. In Europe, Cipralex has, in addition to GAD, also been approved for the treatment of depression, social disorders, and panic disorders, which means the drug...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly